pellucid marginal degeneration

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome	Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, corneal disorder, eye disorder, hereditary disease, intellectual disability, keratoconus, nervous system disorder, pellucid marginal degeneration	Recruiting	Phase 3	2026-02-02	NCT07135167
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases	corneal disorder, eye disorder, keratoconus, pellucid marginal degeneration	Recruiting	Phase 3	2026-02-02	NCT07124910
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia	corneal disorder, corneal ectasia, eye disorder, keratoconus, pellucid marginal degeneration	Recruiting	Phase 2	2025-10-20	NCT04094090

Clinical trials